Medpace Holdings Total Assets 2014-2024 | MEDP

Medpace Holdings total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Medpace Holdings total assets for the quarter ending September 30, 2024 were $2.084B, a 40.18% increase year-over-year.
  • Medpace Holdings total assets for 2023 were $1.657B, a 22.5% increase from 2022.
  • Medpace Holdings total assets for 2022 were $1.352B, a 18.52% decline from 2021.
  • Medpace Holdings total assets for 2021 were $1.66B, a 19.36% increase from 2020.
Medpace Holdings Annual Total Assets
(Millions of US $)
2023 $1,657
2022 $1,352
2021 $1,660
2020 $1,391
2019 $1,143
2018 $968
2017 $951
2016 $979
2015 $984
2014 $1,097
2013 $0
Medpace Holdings Quarterly Total Assets
(Millions of US $)
2024-09-30 $2,084
2024-06-30 $1,920
2024-03-31 $1,796
2023-12-31 $1,657
2023-09-30 $1,487
2023-06-30 $1,407
2023-03-31 $1,396
2022-12-31 $1,352
2022-09-30 $1,328
2022-06-30 $1,315
2022-03-31 $1,344
2021-12-31 $1,660
2021-09-30 $1,577
2021-06-30 $1,470
2021-03-31 $1,451
2020-12-31 $1,391
2020-09-30 $1,296
2020-06-30 $1,222
2020-03-31 $1,138
2019-12-31 $1,143
2019-09-30 $1,072
2019-06-30 $1,017
2019-03-31 $1,007
2018-12-31 $968
2018-09-30 $950
2018-06-30 $968
2018-03-31 $973
2017-12-31 $951
2017-09-30 $949
2017-06-30 $964
2017-03-31 $966
2016-12-31 $979
2016-09-30 $976
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2014-12-31 $1,097
2013-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Services $10.202B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00